Skip to main content

Search Videos and More

Showing 97 - 112 of 136 results

Previous| 1... 6 | 7 | 8 ...9 |Next

Not Every Patient With HCC is the Same: The Need for More Equitable Liver Cancer Screening

Not Every Patient With HCC is the Same: The Need for More Equitable Liver Cancer Screening

Center of Excellence for Liver and Bile Duct Cancer

Center of Excellence for Liver and Bile Duct Cancer

Early Lung Cancer Coopts Immune Cell Into Helping Tumors Invade the Lungs, Mount Sinai Researchers Discover

Early Lung Cancer Coopts Immune Cell Into Helping Tumors Invade the Lungs, Mount Sinai Researchers Discover

Bladder Cancer Treatment Without Cystectomy

Bladder Cancer Treatment Without Cystectomy

Anti-HER2 Treatments Can Cause Pulmonary Toxicities in HER2+ Breast Cancer

Anti-HER2 Treatments Can Cause Pulmonary Toxicities in HER2+ Breast Cancer

Myeloid Cell-associated Resistance to PD-1/PD-L1 Blockade in Urothelial Cancer Revealed Through Bulk and Single-cell RNA

Myeloid Cell-associated Resistance to PD-1/PD-L1 Blockade in Urothelial Cancer Revealed Through Bulk and Single-cell RNA

NYEE’s Ocular Oncology Service Expanded Patient Options for Eye Cancer Treatment

NYEE’s Ocular Oncology Service Expanded Patient Options for Eye Cancer Treatment

Personalized Cancer Vaccine Guided by Mount Sinai Computations Is Safe, Shows Potential Benefit Against Multiple Tumor Types

Personalized Cancer Vaccine Guided by Mount Sinai Computations Is Safe, Shows Potential Benefit Against Multiple Tumor Types

The Tisch Cancer Institute Specialty Report 2021

The Tisch Cancer Institute Specialty Report 2021

What’s New in Gynecologic Cancer Treatment?

What’s New in Gynecologic Cancer Treatment?

Deirdre J. Cohen, MD, MS, Appointed as Director of Gastrointestinal Oncology Program of Mount Sinai Health System

Deirdre J. Cohen, MD, MS, Appointed as Director of Gastrointestinal Oncology Program of Mount Sinai Health System

The Tisch Cancer Institute Earns Second Consecutive Designation From National Cancer Institute

The Tisch Cancer Institute Earns Second Consecutive Designation From National Cancer Institute

Phase 1 Study Supports the Use of Rigosertib in Combination With Azacitidine to Treat Myelodysplastic Syndrome

Phase 1 Study Supports the Use of Rigosertib in Combination With Azacitidine to Treat Myelodysplastic Syndrome

Should Patients Wait To Receive Cancer Treatment?

Should Patients Wait To Receive Cancer Treatment?

Telemedicine As An Option for Cancer Treatment

Telemedicine As An Option for Cancer Treatment

Safety Protocols In The Department of Surgery

Safety Protocols In The Department of Surgery

Showing 97 - 112 of 136 results

Previous| 1... 6 | 7 | 8 ...9 |Next